Martijn van Oijen

Martijn van Oijen is a prominent figure in the field of oncology, specifically focusing on renal cell carcinoma (RCC). He currently serves as a Board Member at the PRO-RCC Foundation, an organization dedicated to the prospective collection of clinical data and patient-reported outcomes related to RCC in the Netherlands. This initiative aims to enhance observational research and facilitate interventional studies within a real-world setting.14

Professional Background

• Current Role: Board Member at PRO-RCC Foundation since October 2021, where he contributes to innovation and policy development in cancer care.3
• Affiliation: He is associated with Amsterdam UMC, where he is involved in various research projects concerning cancer treatment and outcomes.45

Research Contributions

Martijn van Oijen has been actively involved in research that focuses on improving treatment protocols for RCC. His work includes:

• Developing prognostic models for advanced RCC.2
• Participating in studies that evaluate patient-reported outcomes and experiences, which are crucial for understanding the effectiveness of cancer treatments from the patient's perspective.12

Expertise

His expertise lies in:

• Oncology, particularly renal cell carcinoma.
• Patient-reported outcome measures (PROMs) and experience measures (PREMs).
• Collaborative research initiatives aimed at improving cancer treatment methodologies.

Martijn van Oijen's contributions are significant in advancing the understanding and treatment of renal cell carcinoma, making him a key player in this area of medical research.